My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Bausch Health Companies Inc. Common Stock (NY:BHC)

6.650 -0.140 (-2.06%)

Official Closing Price Updated: 4:10 PM EST, Jan 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio? ↗

September 22, 2024

Federal Reserve's rate cut boosted tech, construction, industrial, machinery, and financial sectors. Top-performing mid-cap stocks last week.

Via Benzinga

Topics Economy

Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues ↗

September 16, 2024

Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a spin-off.

Via Benzinga

Topics Supply Chain

Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It? ↗

September 16, 2024

Bausch + Lomb is reportedly considering a sale. But its potential acquirers could come up against antitrust concerns.

Via Investor's Business Daily

Bank Of Canada Cuts Rates Again As Inflation, Labor Market Cool: Canadian Stocks Rebound, Loonie Strengthens ↗

September 04, 2024

Bank of Canada cuts key policy rate by 25 basis points to 4.25% and suggests further cuts if inflation continues to ease.

Via Benzinga

Topics Economy

Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners

August 13, 2024

Via ACCESSWIRE

Bausch Health Announces Second Quarter 2024 Results

July 30, 2024

Via ACCESSWIRE

Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings ↗

July 29, 2024

The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting.

Via Benzinga

Topics Economy

Bausch Health Responds to Market Rumors

July 24, 2024

Via ACCESSWIRE

Bausch Health Solvency Remains A Concerns, Analyst Downgrades Stock ↗

August 02, 2024

Bausch Health reports Q2 2024 GAAP EPS of $0.03, missing the consensus of $0.28. Revenue hits $2.403 billion, up 11% YoY. Piper Sandler downgrades BHC to Underweight with a price target of $3, citing...

Via Benzinga

US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday? ↗

August 01, 2024

Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively impacted investor risk sentiment, just a day after the Federal Open Market...

Via Benzinga

Bausch Health Welcomes Two New Members to the Executive Leadership Team

July 19, 2024

Via ACCESSWIRE

Bausch Health Announces 2024 Annual Meeting of Shareholder Results

May 15, 2024

Via ACCESSWIRE

Why Bausch Health Companies Shares Are Falling After Q1 Results ↗

May 02, 2024

Bausch Health misses Q1 EPS estimates at 59 cents, despite a revenue increase of 11%.

Via Benzinga

Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November ↗

August 01, 2024

After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. The major index futures point to a higher opening, although suggesting a...

Via Benzinga

BHC Stock Plunges as Bausch Health Appears on the Brink of Bankruptcy ↗

July 24, 2024

Although Bausch Health has denied rumors that it’s on the cusp of bankruptcy, BHC stock is nevertheless suffering from skepticism.

Via InvestorPlace

Topics Bankruptcy

Why Bausch health Shares Are Falling Today ↗

July 24, 2024

Bausch Health Companies Inc. (NYSE: BHC) is experiencing a sharp decline in its stock price Wednesday. The drop was triggered by a report suggesting the company is negotiating a potential prepackaged...

Via Benzinga

Topics Bankruptcy

Bausch Health Announces First Quarter 2024 Results

May 02, 2024

Via ACCESSWIRE

Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 24, 2024

Via Benzinga

Stocks Plummet After Tech Earnings, Manufacturing Data ↗

July 24, 2024

The Dow Jones Industrial Average is down triple digits, while the S&P 500 Index eyes its worst daily percentage drop since September 2023.

Via Talk Markets

Topics Stocks

Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024

July 11, 2024

Via ACCESSWIRE

Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals

June 20, 2024

Via ACCESSWIRE

Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences

June 14, 2024

Via ACCESSWIRE

Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults

May 23, 2024

Via ACCESSWIRE

Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024

May 17, 2024

Via ACCESSWIRE

Bausch Health Announces Updates Related to Norwich XIFAXAN Matters

May 14, 2024

Via ACCESSWIRE

Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)

May 09, 2024

Via ACCESSWIRE

Why Bausch Health Companies Stock Dived by More Than 7% Today ↗

May 02, 2024

A large red number on the bottom line attracted the wrong kind of investor attention for the company.

Via The Motley Fool

BHC Stock Earnings: Bausch Health Companies Misses EPS, Misses Revenue for Q1 2024 ↗

May 02, 2024

BHC stock results show that Bausch Health Companies missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

Bausch Health to Announce First-Quarter 2024 Results on May 2

April 11, 2024

Via ACCESSWIRE

Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029

April 11, 2024

Via ACCESSWIRE

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.